SCHEMBL3612079

SCHEMBL3612079

O=S(=O)=NS(=O)(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.55
▸ ALDH1A1 P00352 4/20 0.52
▸ HTT P42858 1/20 0.52
▸ LMNA P02545 2/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ HTR6 P50406 1/20 0.46
▸ TTR P02766 1/20 0.46
▸ MAPT P10636 3/20 0.44
▸ TDP1 Q9NUW8 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA3 P07451 1/20 0.42
▸ CA4 P22748 1/20 0.42
▸ CA6 P23280 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ CA7 P43166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL7060116 0.84 KMT2A (0.65) KDM4EALDH1A1LMNANPSR1KMT2A
SCHEMBL22202124 0.79 KDM4E (0.58) KDM4EALDH1A1HTTLMNANPSR1
SCHEMBL29386682 0.77 HTR6 (0.42) KDM4EALDH1A1HTTLMNAKMT2A
SCHEMBL2146486 0.77 CYP2C19 (0.63) KDM4EALDH1A1HTTLMNANPSR1
SCHEMBL28329307 0.76 CA12 (0.40) ALDH1A1CA12CA1CA2CA9
SCHEMBL544207 0.74 HTR6 (0.55) KDM4EALDH1A1HTTLMNANPSR1
SCHEMBL6172350 0.72 HTR6 (0.52) KDM4EALDH1A1HTTLMNANPSR1
SCHEMBL3520533 0.72 CA1 (0.55) KDM4EALDH1A1HTTLMNANPSR1
SCHEMBL14129274 0.71 TTR (0.60) KDM4EALDH1A1HTTLMNANPSR1
SCHEMBL17808674 0.70 HTR6 (0.50) KDM4EALDH1A1HTTLMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240339661-A1 SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS ENEVATE CORP (US) 2024-10-10 — — US claimed
CN-110392679-B Heterocyclic compounds useful as dual ATX/CA inhibitors 豪夫迈·罗氏有限公司 2023-04-07 — — CN claimed
US-4215209-A ACRYLATE ESTER MONOMER, FREE RADICAL INHIBITOR, CHELATOR AND A SULFONAMIDE OR TERT-AMINE ACCELERATOR NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1980-07-29 — — US claimed
US-20250147230-A1 OPTICAL FIBER AND METHOD FOR MANUFACTURING OPTICAL FIBER FURUKAWA ELECTRIC CO., LTD. (JP) 2025-05-08 — — US disclosed
US-20240339661-A1 SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS ENEVATE CORP (US) 2024-10-10 — — US disclosed
WO-2024162068-A1 OPTICAL FIBER AND METHOD FOR MANUFACTURING OPTICAL FIBER 古河電気工業株式会社 2024-08-08 — — WO disclosed
WO-2023248847-A1 BIPOLAR STORAGE BATTERY AND PRODUCTION METHOD THEREFOR 古河電気工業株式会社 2023-12-28 — — WO disclosed
US-20230416262-A1 TRPML MODULATORS CASMA THERAPEUTICS, INC. 2023-12-28 — — US disclosed
CN-110392679-B Heterocyclic compounds useful as dual ATX/CA inhibitors 豪夫迈·罗氏有限公司 2023-04-07 — — CN disclosed
WO-2021127333-A1 TRPML MODULATORS CASMA THERAPEUTICS, INC. (US) 2021-06-24 — — WO disclosed
EP-3674272-A1 COATING MATERIAL FOR OPTICAL FIBER, COATED OPTICAL FIBER, AND METHOD FOR PRODUCING COATED OPTICAL FIBER FURUKAWA ELECTRIC CO., LTD. (JP) 2020-07-01 — — EP disclosed
US-20200181417-A1 COATING MATERIAL FOR OPTICAL FIBER, COATED OPTICAL FIBER, AND MANUFACTURING METHOD OF COATED OPTICAL FIBER FURUKAWA ELECTRIC CO., LTD. (JP) 2020-06-11 — — US disclosed
US-10246538-B2 Photocurable resin composition, cured product of same and method for producing cured product THREE BOND CO., LTD. (JP) 2019-04-02 — — US disclosed
US-20170313801-A1 Photocurable Resin Composition, Cured Product of Same and Method for Producing Cured Product THREE BOND CO., LTD. (JP) 2017-11-02 — — US disclosed
EP-3216810-A1 PHOTOCURABLE RESIN COMPOSITION, CURED PRODUCT OF SAME AND METHOD FOR PRODUCING CURED PRODUCT Three Bond Co., Ltd. (JP) 2017-09-13 — — EP disclosed
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES NETTEKOVEN MATTHIAS 2010-05-13 — — US disclosed
EP-0219429-B1 SUBSTITUTED BENZENESULFONAMIDE AND ANTIGLAUCOMA FORMULATIONS CONTAINING THEM MERCK & CO. INC. (US) 1989-12-20 — — EP disclosed
US-4678855-A CARBONIC ANHYDRASE INHIBITORS, GLAUCOMA MERCK & CO., INC. (US) 1987-07-07 — — US disclosed
EP-0219429-A1 Substituted benzenesulfonamide and antiglaucoma formulations containing them MERCK & CO. INC. (US) 1987-04-22 — — EP disclosed
US-4215209-A ACRYLATE ESTER MONOMER, FREE RADICAL INHIBITOR, CHELATOR AND A SULFONAMIDE OR TERT-AMINE ACCELERATOR NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1980-07-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HRH3, HRH4, HRH1 KDM4E 1006/4885ALDH1A1 430/4885HTT 747/4885
US-20240339661-A1 SYMMETRICAL OR ASYMMETRICAL ALKYLSULFONYL IMIDE OR CYCLIC ALKYLENE SULFONYLIMIDE SALTS AS CATHODE ADDITIVES, ELECTROLYTE ADDITIVES, OR SI ANODE ADDITIVES FOR SI ANODE-BASED LI-ION CELLS HCN2, IDH2, KCNJ1 KDM4E 2428/4885ALDH1A1 1812/4885HTT 3043/4885
US-20230416262-A1 TRPML MODULATORS TRPM2, TRPM4, TRPM5 KDM4E 2480/4885ALDH1A1 3737/4885HTT 1696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback